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tion of the pulmonary vein ostia plays a major role, as the 
goal in eliminating AF signals is to produce a lesion that 
spans the full thickness of the tissue. The Achilles’ heel of 
the technique is that it was soon recognised that early PV 
reconnection may occur after ablation [6].
Yokoyama’s group [7] was the first to describe an impor-
tant link between the tissue contact force (CF) of the cath-
eter and the size of the lesion, leading to the creation of 
more steerable sheaths and, finally, force-sensing catheters. 
This recent advance in catheter-based radiofrequency abla-
tion allows measurement of electrode-tissue interaction dur-
ing the ablation procedure, thereby facilitating optimisation 
of the CF required for optimal ablation [8], ensuring that 
energy is adequately transmitted to the tissue, while mini-
mising the risks associated with very high contact forces, 
such as chances of thrombus formation, steam pop forma-
tion and cardiac perforation. Use of this CF catheter in the 
SMART-AF trial, a prospective, multicentre trial, improved 
outcome in that the success rate, defined as 12 months’ free-
dom from symptomatic atrial arrhythmias, was 81 vs. 66 % 
in a historical control study [9].
Another approach is to perform stand-alone AF surgery, 
which should be considered, as presented by the Expert 
Consensus Statement, for symptomatic AF patients who 
prefer a surgical approach or when one or more attempts 
at catheter ablation have failed, or for patients who are not 
candidates for catheter ablation. Although this approach 
achieves higher arrhythmia-free success rates after a single 
procedure, lesions are not always transmural [10]. Espe-
cially the isthmus lines of both the mitral and tricuspid valve 
are difficult to ablate from an epicardial aspect [11].
Recent collaboration between electrophysiologists and 
cardiac surgeons introduced the best of both worlds, thereby 
creating a convergent ablation which seems to be an attrac-
Atrial fibrillation (AF) is the most common clinically signif-
icant arrhythmia and is associated with increased mortality 
and morbidity, more specifically stroke and heart failure [1, 
2]. The incidence and prevalence of AF is rising with incre-
ments of age, and, within an ageing population, an escala-
tion of disease burden is to be expected [2]. During the past 
decade, major advances have been made in both surgical 
techniques for ablation of AF, using either standard or mini-
mally invasive techniques, and catheter ablation of AF [3].
Over 15 years ago, foci of ectopic beats initiating at the 
pulmonary veins (PV) were recognised as a trigger for AF, 
thereby forming the basis for developing catheter ablation 
[4]. Ever since, the creation of electrical insulation lesions 
around the pulmonary veins has been the hallmark of cathe-
ter ablation. However, event-free survival rates differ based 
on patient characteristics and type of AF. The estimate of 
efficacy of a single-ablation procedure on an ‘optimal’ can-
didate with paroxysmal AF is approximately 60–80 %. Con-
versely, when performed in patients with persistent AF, the 
success rate drops to 50–70 % [5]. Also, anatomical varia-
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tive alternative to overcome limitations inherent to each 
approach [12].
In the present issue of the Netherlands Heart Journal, 
Kumar et al. [13] are the first to implement the CF catheter 
in such a hybrid approach. They showed that the CF catheter 
also improved outcome when used in a hybrid approach. 
After a median follow-up time of approximately 12 months, 
33 out of 38 patients (87 %) remained in sinus rhythm with-
out requiring antiarrhythmic drugs compared with 21 out 
of 30 patients (70 %) in the control group. Interestingly, all 
patients with recurrent arrhythmias retrospectively had a 
catheter-based touch-up in which CF was below 10 g, and 
thereby significantly below the optimal CF of 18 g, sug-
gesting that CF had been suboptimal during the procedure. 
Importantly, the use of the CF catheter was associated with 
a shorter procedure time, and did not increase the number of 
serious adverse events [13].
Nonetheless, given the small number of patients and the 
single-centre nature of the study by Kumar et al., randomised 
multicentre clinical trials by experienced investigators are 
required, not only to determine the true usefulness of the CF 
catheters in a hybrid approach, but also to analyse whether 
a (staged) hybrid approach improves long-term event-free 
survival.
Importantly, in the future, further technological advances 
may allow more accurate preoperative localisation of AF 
triggers, which may further shorten procedure times and 
may lead to tailored treatment and improved outcome of 
ablation of AF [14]. Nevertheless, it should be noted that 
despite all the technological advances and better-quality 
treatment strategies that have led to improved outcomes of 
AF over the past decades, the pathophysiological mecha-
nisms that underlie this frequently occurring phenomenon 
are still incompletely understood. It is well known that AF 
begets AF and in-depth analyses of this pathway may pos-
sibly provide more insight into AF pathophysiology. With 
the predicted growing number of patients with AF as a result 
of an ageing population and increasing comorbidities in the 
general population, a better understanding of these underly-
ing mechanisms is imperative to reduce the number of AF 
patients and the costs associated with diagnosis and treat-
ment of these patients to the healthcare system.
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